HPV and Head & Neck Cancer

Subject: 148 Infection Control
Credits: 1.5
Tuesday, Aug. 31: 7:30–9 p.m. CDT
Audience: Dentists
Fee: $125 (nonmembers); $75 (members); $37.50 (students)

Description

Human papillomavirus (HPV) is the most common sexually transmitted disease (STD). But, as we think about its role as an STD, we must understand that this virus is also a cause of oral cancers. There are over 135 million HPV infections in North America alone, and HPV accounts for up to 70% of the 45,000 squamous cancers of the head and neck.

Learning Objectives

• Review several case studies of patients with HPV at different stages.
• Review the highlights of the molecular pathology of HPV and how this unique viral model has revealed new pathways in carcinogenesis.
• Review the management of patients at risk for, and those with, HPV infections both in the short and long terms.
• Review the technology and policy for HPV vaccines and ways to prevent oral and genital cancers.

 Register now

Speaker Bio 
 
Ronald C. McGlennen, MD, is president, medical director and founder of Access Genetics and was previously associate professor of pathology at the University of Minnesota Medical School. He has published more than 70 scientific articles and book chapters and has been the editor of five journals. He holds nine issued and pending patents. He is board certified in anatomic and clinical pathology and by the American Board of Medical Genetics and Genomics, with a specialty in clinical molecular genetics. McGlennen is internationally recognized as an expert in molecular biology and genetics. His focus in research has been on reducing the complexity of gene-based testing, including DNA chip technology and simple analytic instrumentation, to better serve the laboratory community. He has served on a series of governmental and regulatory committees focused on the growth of the field of molecular diagnostics.